Product details

Product details
By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

PeopleSoft Inc, the second largest enterprise software provider in the world, had been thwarting the hostile takeover attempt made by the Silicon Valley database giant, Oracle Corporation, since mid-2003. But Oracle has been relentlessly making unsuccessful attempts to take over PeopleSoft. Though its previous takeover attempts failed, on 19 November 2004, Oracle met with some success when a majority of PeopleSoft''s shareholders expressed their support to its offer. Despite the shareholders'' support for the bid, Oracle still has to wait for the approval from the Delaware''s Chancery Court for elimination of the final barrier - the ''Poison Pill'' and the invalidation of the Customer Assurance Programme, provisions inducted by PeopleSoft to prevent the takeover. The case study traces Oracle''s hostile takeover bid efforts, and PeopleSoft''s combat strategies to thwart the bid. The case also presents an insight into the potential advantages and disadvantages to the two companies, their shareholders and customers, in the event of Oracle''s success.
Location:
Other setting(s):
2003-2004

About

Abstract

PeopleSoft Inc, the second largest enterprise software provider in the world, had been thwarting the hostile takeover attempt made by the Silicon Valley database giant, Oracle Corporation, since mid-2003. But Oracle has been relentlessly making unsuccessful attempts to take over PeopleSoft. Though its previous takeover attempts failed, on 19 November 2004, Oracle met with some success when a majority of PeopleSoft''s shareholders expressed their support to its offer. Despite the shareholders'' support for the bid, Oracle still has to wait for the approval from the Delaware''s Chancery Court for elimination of the final barrier - the ''Poison Pill'' and the invalidation of the Customer Assurance Programme, provisions inducted by PeopleSoft to prevent the takeover. The case study traces Oracle''s hostile takeover bid efforts, and PeopleSoft''s combat strategies to thwart the bid. The case also presents an insight into the potential advantages and disadvantages to the two companies, their shareholders and customers, in the event of Oracle''s success.

Settings

Location:
Other setting(s):
2003-2004

Related